About this Research Topic
Mechanisms of PCa progression and drug resistance are poorly understood, in spite of current advances in understanding of the genomic landscape of the different stages of disease. The goal of this Research Topic is to generate a collection of articles with the latest insights into PCa progression and mechanisms of drug resistance. Secondly, generating an overview of current model systems, i.e. organoids, xenograft, PCa cell lines, to study CRPC is a separate objective. Novel model systems to study AR-negative CRPC that underwent lineage plasticity are of great interest to the collection.
For this Research Topic, Original Research articles and Methods papers are preferred. Additionally, Reviews will be considered. Manuscript within the following subjects would be a great addition to this collection.
-Mechanisms of PCa initiation, progression and metastasis
-Mechanisms of drug resistance
-Model systems for prostate cancer research
-Drug targets of CRPC
-CRPC biology and genomics
-Biomarkers for CRPC (subtypes)
-Normal prostate biology relevant to CRPC
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: Prostate Cancer, Anti-androgen therapy, Drug resistance, Lineage Plasticity, Castration Resistance
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.